Biosimilar Value
Patient support services and
Patient support services and
programs to assist with access
The Role of Biosimilars in Value-Based Care
With drug costs being the top barrier to successful outcomes in value-based care payment models, lower-cost biosimilars can play a role in achieving cost savings while maintaining high quality of care.
How practices can leverage cost savings:- An OCM-participating practice highlighted that 7% of the practice’s OCM savings came from biosimilar use alone*
- Lower-cost biosimilars may reduce patients’ co-pays, deductibles, and out-of-pocket costs
- An opportunity to educate staff and build awareness among patients regarding the impact biosimilars can have in patient treatment
The greater availability of biosimilars may offer the opportunity to improve quality of care while reducing costs.
